☕️ No, BoA’s new Palantir street “high” isn’t the highest

Howdy! 👋 

The S&P 500 hit a fresh record this morning but has since rolled a skosh “red” – meaning to the downside – as I type. 

• The world’s best companies continue to power up. 

• The path of least resistance is still higher. 

• Innovation is accelerating. 

Of course, investors tapped into all three are making out like proverbial bandits. 

I hope you’re one of ‘em! 💯 

Missing opportunity is always more expensive than trying to avoid risks you can’t control. 

Here’s my playbook. 

1 – $100B reasons every AI doubter just got left in the dust 

Nvidia just dropped $100B in a tie up with OpenAI. (Read) 

Not surprisingly, the entire chip sector lit up like a big ol’ Las Vegas neon sign. 

In fact, it sparked a global chip rally. (Read) 

Keith’s Investing Tip: Fear, uncertainty and doubt – FUD – are normal so don’t let that derail your investing goals, your plans and your actions. There is an entirely new generation of millionaires being minted right now.  

2 – A “street” high – puuuulease 

The social media squad is going bananas over a new “street high” of $215 from BoA this morning. Up from $180. 

The 5 with Fitz and One Bar Ahead® families know better. 

Here’s what I said a month ago on Fox Business. (Watch) 

You know what to do. 

And, if for some reason you don’t, I’d love to toss my hat in the ring. The One Bar Ahead® Family knew about Palantir on day one and long before most investors and “the street” could spell the company’s name. 

It’s still very early days, imho. 

3 – Kenvue: buy, sell or hold? 

Shares of Kenvue — the maker of Tylenol — bounced 6% today after hitting record lows yesterday. The move came after headlines tied Tylenol use during pregnancy to autism — a claim regulators stress isn’t backed by scientific evidence. (Read) 

The FDA says it will update labels to reflect a possible link between acetaminophen and neurological conditions during pregnancy but emphasized no causal relationship exists. WHO and European regulators agree there’s nothing new here. 

“They” said the same thing about tobacco. 🤦‍ 

I’d rather own companies without the baggage and the drama. 

One of my faves in the medical space, for example, is pushing ahead with all sorts of innovative therapies, robust pipelines, and dependable revenue streams AND spinning off an incredible dividend too. 

It’s returned +29.43% year-to-date versus the S&P 500, which has turned in +14.78%. Kenvue, meanwhile, is –15.35% YTD. 

Hopefully, you’re on track with this in your own portfolio or thinking similarly. 

Consistent income AND growth can make for mighty good returns, particularly if you’ve got the confidence and a rock-solid strategic investing plan needed to ride through the short-term noise that trips up a lot of folks. 

Keith’s Investing Tip: Many if not most investors dramatically underestimate the power of dividends when it comes to building wealth. So they fall behind because they’re only thinking about income when growth often goes hand in hand. 

4 – Boeing bouncing back? 

I love an underdog. 

Case in point, Boeing just locked down a whopper of a deal. 

Uzbekistan Airways signed for up to 22 Dreamliners in a deal worth more than $8 billion. The largest commercial aircraft agreement ever in Central Asia. Some 14 firm 787s, plus options for 8 more. (Read) 

I still don’t like the stock as an investment, but LEAPs calls could be an interesting trade. 

Why? 

LEAPs calls require a fraction of the capital to buy, limit downside and give you tremendous upside if Boeing does take off – pun absolutely intended. 

5 – What the H1-B visa wars could mean for your money 

I’m watching this very, very carefully. 

US President Donald Trump has assessed a $100,000 per year fee on specialist visas in an attempt to keep jobs in the United States. (Read) 

Word from my friends in low places is that Silicon Valley is already considering moving high-paying jobs overseas in response. Or not bringing ‘em here in the first place. 

The media is beginning to pick up on this, too, (Read) 

I’ll leave the politics to everybody else. 

My concern is that this policy backfires and, in doing so, negatively impacts tech innovation and investment potential. 

Six of 10 of the “Magnificent 10” tech companies CEOs came to the US initially on some form of visa. 

• Sundar Pichai (Alphabet) — Student (F-1) → later H-1B early in his career. 

• Satya Nadella (Microsoft) — Student path; later switched to H-1B (famously gave up a green card).  

• Elon Musk (Tesla) — Came to the U.S. on a student visa, later worked on an H-1B; details differ by source, but multiple reputable reports confirm the student-to-H-1B path.  

• Hock Tan (Broadcom) — Arrived in 1971 on a student visa (MIT scholarship).  

• Jensen Huang (Nvidia) — Immigrated as a child (age ~9) with family in 1973 (i.e., not an H-1B).  

• Lisa Su (AMD) — Immigrated as a toddler (age ~3) with parents (i.e., not an H-1B).  

Hmmm. 🤔 

Bottom Line 

People are so busy trying to predict the unpredictable that they forget to think about the profitable. 

Just sayin’. 

As always, let’s MAKE it a great day. 

You got this – I promise! 

Keith 😀